Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks
Nancy Palechor-Ceron(Georgetown University), Xuefeng Liu(Georgetown University), Fleesie Hubbard(University of Maryland, Baltimore), Yun‐Ling Zheng(Georgetown University), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), John F. Deeken(Inova Health System), Aleksandra Dakic(Georgetown University), Ewa Krawczyk(Georgetown University), Bruce J. Davidson(Georgetown University), Priscilla A. Furth(Georgetown University), Sujata Maiti Choudhury(Vidyasagar University), Seema Agarwal(Girls Incorporated), Vera Simić(Georgetown University), Hancai Dan(University of Maryland, Baltimore), Hang Yuan(Jiangnan University), Peter H. Ahn(Georgetown University), Richard Schlegel(Georgetown University), Xuexun Zhou, Kevin J. Cullen(University of Maryland, Baltimore), Weisheng Wang(Hunan University), Jan Blancato(Georgetown University), Chong-xian Pan(VA Northern California Health Care System)
Cited by 84
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
|Genome biology|2007|1.3k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
|American Journal Of Pathology|2011|738